Many people who live with asthma manage their symptoms by identifying and avoiding triggers, taking daily oral and inhaled medications, and using a quick-relief inhaler. Recently, many new drugs known as biologics have been approved for treating moderate-to-severe asthma. Biologic therapies are antibodies (immune proteins) that target specific molecules that contribute to poorly controlled asthma.
There are many new biologic therapy options available to treat severe asthma. They work by disrupting the pathways that lead to inflammation in the body that causes asthma symptoms. Xolair and Nucala are approved for patients as young as six years old, while Dupixent and Fasenra are approved for patients as young as 12 years old. Cinqair is approved for adults 18 years and over.
Biologic therapy may not work for everyone and it may require the use of other treatments as well, but the vast majority of patients on biologic therapy have significant improvement in their asthma symptoms and also require far less if any oral steroids. It is important to see an asthma specialist in order to learn if biologic treatment is right for you. Our experts at AAFAC can help you identify what triggers your asthma and find the treatment that is unique to you and your needs.